Krebs Jessica, Wasner Sonja, Egloffstein Sainab, Lux Michael P, Morawa Eva, Beckmann Matthias W, Erim Yesim
Psychosomatische und Psychotherapeutische Abteilung, Universitätsklinikum Erlangen.
Frauenklinik, Universitätsklinikum Erlangen, CCC Erlangen-EMN, Friedrich-Alexander-Universität Erlangen-Nürnberg.
Psychother Psychosom Med Psychol. 2019 Jul;69(7):293-300. doi: 10.1055/a-0668-1206. Epub 2018 Oct 16.
The objective of the study was to find out about psychological distress, fear of progression, and resilience levels in patients with breast cancer and gynecological tumors asking for a second opinion concerning their oncological treatment.
158 female cancer patients were assessed for those parameters in a questionnaire survey comprising SOC-13, FoP-Q-SF, and the NCCN distress thermometer.
16.2% of the breast cancer patients and 20.5% of the patients with gynecological tumors suffered from dysfunctional fear of progression, 70.4% of the breast cancer patients and 80.6% of the patients with gynecological tumors were highly distressed. The patients did not differ significantly in their resilience levels from a representative sample of the general population.
Strong disease-related fear and distress were found in participating patients seeking a second medical opinion.
Further study of the connection between psychological variables and the decision for a second oncological opinion seems crucial concerning implications for doctor-patient-communication.
本研究的目的是了解寻求肿瘤治疗第二意见的乳腺癌和妇科肿瘤患者的心理困扰、疾病进展恐惧及心理弹性水平。
通过包含SOC-13、FoP-Q-SF和NCCN苦恼温度计的问卷调查,对158名女性癌症患者的上述参数进行评估。
16.2%的乳腺癌患者和20.5%的妇科肿瘤患者存在功能失调性的疾病进展恐惧,70.4%的乳腺癌患者和80.6%的妇科肿瘤患者高度苦恼。患者的心理弹性水平与一般人群的代表性样本相比无显著差异。
在寻求第二医疗意见的参与患者中发现了强烈的疾病相关恐惧和苦恼。
鉴于对医患沟通的影响,进一步研究心理变量与寻求第二肿瘤意见决策之间的联系似乎至关重要。